| Fri, Dec 4, 2009 | | | Federman & Sherwood Announces That a Securities Class Action Lawsuit Has Been Filed Against Hemispherx Biopharma, Inc. (AMEX: HEB) Marketwire (Fri 4:27pm)
| | | Hemispherx Upbeat Despite FDA setback at TheStreet.com (Fri 9:30am)
| | | Hemispherx Needs to Face Reality at TheStreet.com (Fri 9:30am)
| | | Biotech Stock Mailbag: Hemispherx Biopharma at TheStreet.com (Fri 7:00am)
| | Wed, Dec 2, 2009 | | | [$$] BioFuel Energy Soars 34%; DRDGold Shines at The Wall Street Journal Online (Wed, Dec 2)
| | | Equities Update: Flat Finish as Energies Weigh at Seeking Alpha (Wed, Dec 2)
| | | Geron, StemCells: Late Day Volume Plays at TheStreet.com (Wed, Dec 2)
| | | Rosen Law Firm Announces Class Action Lawsuit Against Hemispherx Biopharma, Inc. Marketwire (Wed, Dec 2)
| | | Biotech Stocks: Dyax, Santarus, CytRx soar; Hemispherx craters at MarketWatch (Wed, Dec 2)
| | | FDA rejects Hemispherxâs chronic fatigue drug Ampligen at bizjournals.com (Wed, Dec 2)
| | | Biotech Stocks: Dyax rockets, Hemispherx craters on FDA updates at MarketWatch (Wed, Dec 2)
| | | Hemispherx's Ampligen Dealt FDA Blow at TheStreet.com (Wed, Dec 2)
| | | Hemispherx Biopharma Announces Investor Conference Call GlobeNewswire (Wed, Dec 2)
| | | FDA Approves Two New Drugs: BioBuzz at TheStreet.com (Wed, Dec 2)
| | | Hemispherx gets FDA denial on Ampligen treatment AP (Wed, Dec 2)
| | Tue, Dec 1, 2009 | | | HEMISPHERX BIOPHARMA INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online (Tue, Dec 1)
| | | Hemispherx Biopharma Receives Complete Response Letter From FDA on Ampligen(R) New Drug Application for Chronic Fatigue Syndrome GlobeNewswire (Tue, Dec 1)
| | Mon, Nov 23, 2009 | | | BUYINS.NET Issues Hemispherx Biopharma SqueezeTrigger Report; Over 26 Million Shares Shorted in 2009; Next Short Squeeze Expected Above $1.13 GlobeNewswire (Mon, Nov 23)
| | Tue, Nov 17, 2009 | | | Genzyme's Termeer: Worst Biotech CEO of '09 at TheStreet.com (Tue, Nov 17)
| | Mon, Nov 16, 2009 | | | Class Action Lawsuit Against Hemispherx Biopharma is Without Merit GlobeNewswire (Mon, Nov 16)
| Add HEB News to My Yahoo!:

| |
|